Metformin in the prevention of hepatocellular carcinoma in diabetic patients: A systematic review
.: Preventive effect of metformin in hepatocellular carcinoma (HCC) is not entirely clear. We aimed to evaluate the use of metformin as a protective factor of HCC in diabetic patients. .: We carried out an electronic search on PUBMED/MEDLINE, Web of Science and LILACS databases, with no limit of dat...
Main Authors: | Victor Cunha, Helma Pinchemel Cotrim, Raquel Rocha, Kellyane Carvalho, Liliane Lins-Kusterer |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-05-01
|
Series: | Annals of Hepatology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1665268119322720 |
Similar Items
-
Investigating Effect of Rapamycin and Metformin on Angiogenesis in Hepatocellular Carcinoma Cell Line
by: Mandana Rastegar, et al.
Published: (2018-03-01) -
Metformin exhibits the anti-proliferation and anti-invasion effects in hepatocellular carcinoma cells after insufficient radiofrequency ablation
by: Qingyun Zhang, et al.
Published: (2017-04-01) -
Metformin Improves Biochemical and Pathophysiological Changes in Hepatocellular Carcinoma with Pre-Existed Diabetes Mellitus Rats
by: Maysa A. Mobasher, et al.
Published: (2021-01-01) -
Rosiglitazone metformin adduct inhibits hepatocellular carcinoma proliferation via activation of AMPK/p21 pathway
by: Yuyang Liu, et al.
Published: (2019-01-01) -
Metformin modifies disparity in hepatocellular carcinoma incidence in men with type 2 diabetes but without chronic liver diseases
by: Chen‐Pin Wang, et al.
Published: (2019-06-01)